X线与B超结合对照探查胸腔肿瘤的临床意义

目的:探究分析X线与超声结合对照探查胸腔肿瘤的临床意义。方法:选取2016年1月—2019年1月我院收诊的胸腔肿瘤患者60例,经由X线与超声结合对照探查,并进行具体分析。结果:结合临床表现,对所有患者的X线与超声结合对照探查胸腔肿瘤的影像学结果以及诊断结果进行分析。局限性胸膜纤维瘤,检查可见单发性病灶并常发生于胸膜,尤其以脏层胸膜较为多见。由梭形细胞组成,可见不同程度的胶原纤维与丰富的间质血管。可见胸腔积液,其中约有8%可见骨吸收。神经梢瘤,患者常觉肋间神经分布区麻木,一般病灶呈圆形,与胸膜成锐角,会有囊性改变。胸膜间皮瘤,良性胸膜间皮瘤病灶较小,会有石棉接触史。恶性胸膜间皮瘤常见于胸膜,病灶是多发性的软组织肿块,通常边界界限不清,并伴有大量胸腔积液,病变常累及多个组织。结论:X线与超声结合对照探查胸腔肿瘤可以快捷有效的获取诊断结果,对于临床诊断以及治疗具有积极意义,建议在临床广泛推广使用。

中西医结合治疗肺癌合并恶性胸腔积液效果观察

目的:观察中西医结合治疗肺癌合并恶性胸腔积液的临床效果。方法:72例随机分为观察组和对照组各36例。观察组用龙葵葶苈汤口服及顺铂胸腔内灌注化疗联合治疗,对照组用顺铂胸腔内灌注化疗。比较两组治疗后的细胞免疫功能、不良反应及临床疗效。结果:缓解率观察组高于对照组(P<0.05),KPS评分改善率观察组高于对照组(P<0.05),两组不良反应发生率比较差异无统计学意义(P>0.05)。结论:中西医结合治疗肺癌合并恶性胸腔积液可加快康复速度,增强机体免疫功能,改善患者生活质量。

中西医结合治疗急性胰腺炎疗效观察

目的:观察清胰汤配合西药治疗急性胰腺炎的效果。方法:100例分为两组各50例,两组均用西药常规治疗,治疗组加用清胰汤,治疗14天。结果:总有效率治疗组94.00%,对照组76.00%,两组比较有统计学意义(P<0.05)。结论:中西医结合治疗急性胰腺炎疗程短,疗效好。

Efficacy and safety of electroacupuncture for perimenopausal insomnia: a randomized controlled trial

Objective: To observe the effectiveness and safety of electroacupuncture (EA) plus Luohua Anshen oral liquid for patients with perimenopausal insomnia. Methods: A total of 66 participants who met the inclusion criteria were enrolled in the randomized controlled trial and allocated to a treatment group and a control group at a ratio of 1:1, with 33 cases in each group. Both groups were given Luohua Anshen oral liquid as a basic treatment. The treatment group was additionally given EA every other day, three times a week. Both groups were treated for four weeks and a four-week follow-up was conducted. The scores of Pittsburgh sleep quality index (PSQI), Kupperman index (KI) and traditional Chinese medicine sleep syndrome scale (TCMSSS) were recorded at pre- and post-treatment, and at the follow-up. Meanwhile, adverse effects were monitored and recorded. Results: After four-week treatment, the global scores of PSQI, KI and TCMSSS in both groups declined significantly (all P<0.05), and the decreases in the treatment group were more significant than those in the control group (allP<0.05). The global scores of PSQI, KI and TCMSSS in both groups at the follow-up visit were significantly different from the corresponding baseline (allP<0.05), while insignificantly different from those assessed at post-treatment (allP>0.05). The total effective rate was 93.9% in the treatment group, significantly higher than 72.2% in the control group (P<0.05). No significant adverse event was reported in this trial excepted one patient experienced slight dizziness in the first acupuncture treatment. Conclusion: EA plus Luohua Anshen oral liquid is safe for perimenopausal insomnia with satisfactory short- and long-term effectiveness, and it shows certain advantage compared with using Luohua Anshen oral liquid alone.

Integrated traditional and Western medicine for treatment of depression based on syndrome differentiation:a meta-analysis of randomized controlled trials based on the Hamilton depression scale

OBJECTIVE:To systematically review the benefits of integrated traditional and Western medicine therapies based on the Hamilton depression scale(HAMD) following syndrome differentiation of depression.METHODS:We searched six English and Chinese electronic databases for randomized clinical trials(RCTs) on integrated traditional and Western medicine for treatment of depression.Two authors extracted data and independently assessed the trial quality.RevMan 5 software was used for data analyses with an effect estimate presented as weighted mean difference(WMD) with a 95% confidence interval(CI).RESULTS:Seven RCTs with 576 participants were identified for this review.All trials were eligible for the meta-analysis and were evaluated as unclear or having a risk of bias.Meta-analysis showed,compared with Western medicine alone,integrated traditional and Western medicine based on syndrome differentiation could improve the effect of treatment represented by the HAMD [WMD=-2.39,CI(-2.96,-1.83),Z=8.29,P<0.00001].There were no reported serious adverse effects that were related to integrated traditional and Western medicine based therapies in these trials.CONCLUSIONS:Integrated traditional and Western medicine based therapies for the syndrome differentiation of depression significantly improved the HAMD,illustrating that combining therapies from integrated traditional and Western medicine for treatment of depression is better than Western medicine alone.However,further large,rigorously designed trials are warranted due to the insufficient methodological rigor seen in the trials included in this study.

Effect of Jianpi therapy in treatment of chronic obstructive pulmonary disease:a systematic review

OBJECTIVE： To evaluate the efficacy of Jianpi thera- py in Traditional Chinese Medicine （TCM） for treat- ment of chronic obstructive pulmonary disease （COPD） in stable phase by performing a systematic review and meta-analysis. METHODS： The literatures concerning randomized controlled trials （RCTs） and quasi-RCTs comparing TCM treatment plus Western Medicine （WM） treat- ment with TCM alone, orTCM treatment vs no treatment, placebo for stable phase of COPD were searched in PubMed （1990-December 2010）, in Eng- lish and using Chinese National Knowledge Infra- structure （CNKI, 1990-December 2010）, Chinese Bio- medical Database （1990-December 2010）, Wang- fang Database （1990-December 2010）, and Weipu （VlP） Database in Chinese. The quality assessment and data extraction for RCTs were conducted by two reviewers independently. Jadad scale and allo-cation concealment were used to assess the quality of the included studies, and meta-analyses were conducted with the Collaboration＇s Revman 5.0 software. RESULTS： Seventeen RCTs or quasi-RCTs involving 1269 patients were included. The methodological quality was poor in all trials except one trial （Jadad score=4）. In the meta-analysis, TCM-WM treatment was significantly superior to WM treatment in cure rate [0R=3.82, 95%C/（2.45, 5.95）], and the effective rate between TCM treatment and placebo also had significant difference [0R=4.31, 95%C/（2.35, 7.91）]. Moreover, pulmonary function of the patients in TCM-WM group and TCM group was significantly improved [forced vital capacity （FVC）, P=O.01, quali- ty of life, P〈O.O01 ]. CONCLUSION： The experience in TCM-WM treat- ment of COPD in stable phase was encouraging. The current evidence shows that TCM-WM treat- ment might be more efficient in effective rate, qual- ity of life, and FVC than WM treatment alone. But for forced expiratory volume in one second （FEVl） and FEV1/FVC, no matter TCM-WM treatment com- pared with WM treatment alone or TCM treatment compared with placebo, there was no significant difference, with no obvious adverse reactions. Due to the low methodological quality of trials includ- ed, more RCTs of high quality in large scale are re- quired.